Member login

Forgot Password?

By using the members area you have already agreed to share your personal information with the BBA so that you can access the members materials. We will store your details only as long as you are a member. Your personal information will not be shared any affiliated companies or third parties. For more information about our Privacy Policy, click here.

Return to login
Better access. Better health
Read our guide to Generic and biosimilars medicines market and pricing
Better access to high quality biological medicines
The British Biosimilars Association (BBA) is the expert sector group of the British Generic Manufacturers Association (BGMA) exclusively focused on biosimilars

The British Biosimilars Association (BBA) is the expert sector group of the British Generic Manufacturers Association (BGMA) exclusively focused on biosimilars.

The members of the BBA ensure access to high quality, safe and effective biosimilar medicines for UK patients. As industry experts, we partner with patients’ representatives, healthcare professionals, regulators and payers to increase understanding and to drive a sustainable environment for the development, production and continuing optimised use of biosimilar medicines across the UK.

For more information about Biosimilars, please take a look at NHS England’s ‘What is a Biosimilar’ document.

Twitter

12.07.2019
RT @sarahberry_1: Thanks for inviting me to speak at todays @BritBiosimilars conference. Appreciated the opportunity to talk about the imp of #patientexperience & #shareddecisionmaking at all points of process- from negotiations, product design, delivery, communication & monitoring. #biosimilars
05.07.2019
RT @Britishgenerics: Watch our latest video to discover how the UK #medicines industry works and how generic medicines help secure supply, provide choice and lower prices for the #NHS. You can also read our full report here: https://t.co/caMYGeQVZZ #OxeraGenericMedicines
03.07.2019
@BritBiosimilars director general Warwick Smith kicks things off at our latest Britsh Biosimilars Association Forum - great to see a packed audience in attendance
03.07.2019
RT @KateO_R: Super keen to hear from #UK healthcare stakeholders their vision on increasing patient access to biosimilar medicines #together4health @BritBiosimilars @medicinesforEU @majasercic #biosimilar #accesstomedicines
03.07.2019
RT @clairefmunro: Great to hear so much about collaboration, shared decision-making and the patient perspective at today’s @BritBiosimilars stakeholder foru